[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States API(Active Pharmaceutical Ingredient) Intermediate Market Report 2017

October 2017 | 100 pages | ID: U1AB3BC02B1PEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States API(Active Pharmaceutical Ingredient) Intermediate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of API(Active Pharmaceutical Ingredient) Intermediate in these regions, from 2012 to 2022 (forecast).
United States API(Active Pharmaceutical Ingredient) Intermediate market competition by top manufacturers/players, with API(Active Pharmaceutical Ingredient) Intermediate sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Jigs Chemical
  • Sanofi Winthrop Industrie S.A.
  • Shandong Jiulong Fine Chemical Co., Ltd.
  • Hipharma Limited
  • AMPAC Fine Chemicals
  • BASF
  • Cambrex Corporation
  • A R Life Sciences Pvt. Ltd.
  • Dragon Hwa ChemPharm. Co., Ltd.
  • Ami Life Sciences Pvt. Ltd.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • By Product
    • Biotech Intermediates
    • Chemical Intermediates
  • By Type of Intermediate
    • Patent Intermediates
    • Non-patent Intermediates
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of API(Active Pharmaceutical Ingredient) Intermediate for each application, including
  • Oncology
  • Diabetes
  • Endocrinology
  • Cardiovascular Disease
  • CNS & Neurological Disorders
If you have any special requirements, please let us know and we will offer you the report as you want.
United States API(Active Pharmaceutical Ingredient) Intermediate Market Report 2017

1 API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE OVERVIEW

1.1 Product Overview and Scope of API(Active Pharmaceutical Ingredient) Intermediate
1.2 Classification of API(Active Pharmaceutical Ingredient) Intermediate by Product Category
  1.2.1 United States API(Active Pharmaceutical Ingredient) Intermediate Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States API(Active Pharmaceutical Ingredient) Intermediate Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Biotech Intermediates
  1.2.4 Chemical Intermediates
1.3 United States API(Active Pharmaceutical Ingredient) Intermediate Market by Application/End Users
  1.3.1 United States API(Active Pharmaceutical Ingredient) Intermediate Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Oncology
  1.3.3 Diabetes
  1.3.4 Endocrinology
  1.3.5 Cardiovascular Disease
  1.3.6 CNS & Neurological Disorders
1.4 United States API(Active Pharmaceutical Ingredient) Intermediate Market by Region
  1.4.1 United States API(Active Pharmaceutical Ingredient) Intermediate Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West API(Active Pharmaceutical Ingredient) Intermediate Status and Prospect (2012-2022)
  1.4.3 Southwest API(Active Pharmaceutical Ingredient) Intermediate Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic API(Active Pharmaceutical Ingredient) Intermediate Status and Prospect (2012-2022)
  1.4.5 New England API(Active Pharmaceutical Ingredient) Intermediate Status and Prospect (2012-2022)
  1.4.6 The South API(Active Pharmaceutical Ingredient) Intermediate Status and Prospect (2012-2022)
  1.4.7 The Midwest API(Active Pharmaceutical Ingredient) Intermediate Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of API(Active Pharmaceutical Ingredient) Intermediate (2012-2022)
  1.5.1 United States API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2022)
  1.5.2 United States API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2022)

2 UNITED STATES API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States API(Active Pharmaceutical Ingredient) Intermediate Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States API(Active Pharmaceutical Ingredient) Intermediate Average Price by Players/Suppliers (2012-2017)
2.4 United States API(Active Pharmaceutical Ingredient) Intermediate Market Competitive Situation and Trends
  2.4.1 United States API(Active Pharmaceutical Ingredient) Intermediate Market Concentration Rate
  2.4.2 United States API(Active Pharmaceutical Ingredient) Intermediate Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers API(Active Pharmaceutical Ingredient) Intermediate Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Region (2012-2017)
3.2 United States API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Region (2012-2017)
3.3 United States API(Active Pharmaceutical Ingredient) Intermediate Price by Region (2012-2017)

4 UNITED STATES API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Type (2012-2017)
4.3 United States API(Active Pharmaceutical Ingredient) Intermediate Price by Type (2012-2017)
4.4 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate by Type (2012-2017)

5 UNITED STATES API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Application (2012-2017)
5.2 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Jigs Chemical
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi Winthrop Industrie S.A.
  6.2.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Shandong Jiulong Fine Chemical Co., Ltd.
  6.3.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Hipharma Limited
  6.4.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 AMPAC Fine Chemicals
  6.5.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 BASF
  6.6.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 BASF API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Cambrex Corporation
  6.7.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 A R Life Sciences Pvt. Ltd.
  6.8.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Dragon Hwa ChemPharm. Co., Ltd.
  6.9.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Ami Life Sciences Pvt. Ltd.
  6.10.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MANUFACTURING COST ANALYSIS

7.1 API(Active Pharmaceutical Ingredient) Intermediate Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 API(Active Pharmaceutical Ingredient) Intermediate Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of API(Active Pharmaceutical Ingredient) Intermediate Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume, Revenue Forecast (2017-2022)
11.2 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Forecast by Type (2017-2022)
11.3 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Forecast by Application (2017-2022)
11.4 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of API(Active Pharmaceutical Ingredient) Intermediate
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Market Size (K MT) by Type (2012-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type (Product Category) in 2016
Figure Biotech Intermediates Product Picture
Figure Chemical Intermediates Product Picture
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Endocrinology Examples
Table Key Downstream Customer in Endocrinology
Figure Cardiovascular Disease Examples
Table Key Downstream Customer in Cardiovascular Disease
Figure CNS & Neurological Disorders Examples
Table Key Downstream Customer in CNS & Neurological Disorders
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Market Size (Million USD) by Region (2012-2022)
Figure The West API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Players/Suppliers
Figure 2017 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Players/Suppliers
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Players/Suppliers
Figure 2017 United States API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Players/Suppliers
Table United States Market API(Active Pharmaceutical Ingredient) Intermediate Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market API(Active Pharmaceutical Ingredient) Intermediate Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Market Share of Top 3 Players/Suppliers
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers API(Active Pharmaceutical Ingredient) Intermediate Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers API(Active Pharmaceutical Ingredient) Intermediate Product Category
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Region (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Region (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Region (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Region in 2016
Table United States API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Region (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region in 2016
Table United States API(Active Pharmaceutical Ingredient) Intermediate Price (USD/MT) by Region (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Type (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Type (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type in 2016
Table United States API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Type (2012-2017)
Figure Revenue Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Type (2012-2017)
Figure Revenue Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Type in 2016
Table United States API(Active Pharmaceutical Ingredient) Intermediate Price (USD/MT) by Types (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate by Type (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Application (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application in 2016
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate by Application (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate by Application (2012-2017)
Table Jigs Chemical Basic Information List
Table Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in United States (2012-2017)
Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in United States (2012-2017)
Table Sanofi Winthrop Industrie S.A. Basic Information List
Table Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in United States (2012-2017)
Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in United States (2012-2017)
Table Shandong Jiulong Fine Chemical Co., Ltd. Basic Information List
Table Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in United States (2012-2017)
Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in United States (2012-2017)
Table Hipharma Limited Basic Information List
Table Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in United States (2012-2017)
Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in United States (2012-2017)
Table AMPAC Fine Chemicals Basic Information List
Table AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in United States (2012-2017)
Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in United States (2012-2017)
Table BASF Basic Information List
Table BASF API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in United States (2012-2017)
Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in United States (2012-2017)
Table Cambrex Corporation Basic Information List
Table Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in United States (2012-2017)
Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in United States (2012-2017)
Table A R Life Sciences Pvt. Ltd. Basic Information List
Table A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in United States (2012-2017)
Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in United States (2012-2017)
Table Dragon Hwa ChemPharm. Co., Ltd. Basic Information List
Table Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in United States (2012-2017)
Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in United States (2012-2017)
Table Ami Life Sciences Pvt. Ltd. Basic Information List
Table Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in United States (2012-2017)
Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of API(Active Pharmaceutical Ingredient) Intermediate
Figure Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate
Figure API(Active Pharmaceutical Ingredient) Intermediate Industrial Chain Analysis
Table Raw Materials Sources of API(Active Pharmaceutical Ingredient) Intermediate Major Players/Suppliers in 2016
Table Major Buyers of API(Active Pharmaceutical Ingredient) Intermediate
Table Distributors/Traders List
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Price (USD/MT) Trend Forecast (2017-2022)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) Forecast by Type in 2022
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) Forecast by Application in 2022
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Share Forecast by Region (2017-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Share Forecast by Region (2017-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories